The LEO Foundation Award 2021 – Region EMEA
Grantee: Dr. Beate Lichtenberger, Assistant Professor, Medical University of Vienna
Amount: USD 100,000
Grant category: LEO Foundation Awards
Year: 2021
Geography: Austria
Dr. Beate Lichtenberger is Assistant Professor at the Medical University of Vienna, Austria.
She receives the award for her excellent research aimed at a better understanding of how fibroblasts affect skin cancer, skin regeneration and skin diseases like scleroderma and keloid scars.
The LEO Foundation Award 2016 – Silver Award
Grantee: Dr. Thomas Wiesner
Amount: DKK 500,000
Grant category: LEO Foundation Awards
Year: 2016
Geography: Austria
Presented to Dr. Thomas Wiesner. Dr. Wiesner is breaking new ground to find new mechanism-based cancer therapies. Following medical school, Dr. Wiesner wrote his thesis on the genomic aberrations of cutaneous lymphoma and completed his residency in dermatology at the Medical University of Graz in Austria. Dr. Wiesner spent five years conducting basic and translational research using cutting-edge techniques within high-throughput sequencing techniques in particular. His work within skin cancer research resulted in key discoveries, in particular concerning the genomic landscape of skin tumours.
Based on his experience as a physician-scientist and his access to high-quality clinical samples, Dr. Wiesner plans to combine high-throughput sequencing technologies, computational approaches and functional assays in order to define the relevant genomic and epigenomic aberrations in skin cancer and pave the way for new mechanism-based cancer therapies.
The LEO Foundation Award 2012 – Gold Award
Grantee: David Schrama
Amount: DKK 1,000,000
Grant category: LEO Foundation Awards
Year: 2012
Geography: Austria
Presented to Assistant Professor David Schrama at the Dermatology Department at Graz Medical University, Austria.
Schrama’s research focuses on melanoma biology. His research team currently analyses the impact of genetic diversity among patients and tumours on prognosis and clinical outcome of therapies. In recent years, Schrama’s scientific work has focused on unravelling the biology of another skin cancer; the polyomavirus associated merkel cell carcinoma.